Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
39.9M
-
Shares change
-
-834K
-
Total reported value, excl. options
-
$94.2M
-
Value change
-
-$2.84M
-
Number of buys
-
31
-
Number of sells
-
-60
-
Price
-
$2.36
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q2 2022
105 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q2 2022.
Passage BIO, Inc. - COMMON STOCK (PASG) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.9M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (8.93M shares), Frazier Life Sciences Management, L.P. (5.01M shares), Versant Venture Management, LLC (4.96M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), Deep Track Capital, LP (2.32M shares), VANGUARD GROUP INC (1.84M shares), Woodline Partners LP (1.79M shares), BlackRock Inc. (1.37M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1.24M shares), and Erste Asset Management GmbH (1.17M shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.